HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 73/6/1191    most recent biolreprod.105.044628v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thota, C.S. Articles by Yallampalli, C. Search for Related Content PubMed PubMed Citation Articles by Thota, C.S. Articles by Yallampalli, C. Agricola Articles by Thota, C.S. Articles by Yallampalli, C.

Effects of Parathyroid Hormone Like Hormone (PTHLH) Antagonist, PTHLH_7–34, on Fetoplacental Development and Growth During Midgestation in Rats¹

Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas 77555-1062

ABSTRACT

Parathyroid hormone-like hormone (PTHLH) secretion has been reported in human amnion, chorion, decidual cytotrophoblast, syncytiotrophoblast, endometrium, and myometrium; however, the functions of PTHLH during pregnancy, particularly during placenta formation and fetal development, are not well understood. We examined whether neutralization of PTHLH action using PTHLH antagonist, PTHLH_7–34, in rats during early gestation affects fetal and placental growth. Rats received s.c. a daily dose of either 0, 4, 12, or 36 µg of PTHLH_7–34 infused continuously through mini-osmotic pumps from Day 8 through Day 15 of pregnancy. Fetal weights measured on Day 15 were significantly decreased in rats treated with all the doses of PTHLH_7–34 compared to controls, and decreases in placental weights were significant at the 12-µg dose. TUNEL assay demonstrated an increased number of apoptotic cells in placenta of treated rats, including rats treated with the 4-µg dose. Cleaved caspase 3 (CASP3), caspase 9 (CASP9) (P < 0.05) and poly-ADP-ribose polymerase (PARP1) (P < 0.01) expression was increased and BCL2 (P < 0.01) expression was decreased in rats treated with 4 µg PTHLH_7–34 compared to that in control. Placental cytochrome c expression was increased (P < 0.01) in cytosolic and decreased (P < 0.01) in mitochondrial fraction in PTHLH_7–34-treated rats. Caspase 8 expression was not affected by the treatment. Immunohistochemical analysis of platelet endothelial cell adhesion molecule (PECAM1) showed higher staining intensity in control than in treated rats. In conclusion, these results suggests that PTHLH plays a role in early pregnancy, and that antagonization of PTHLH action causes fetoplacental growth restriction through activation of mitochondrial pathway of apoptosis in the placenta and through decreased expression of PECAM1.

apoptosis, early development, placenta, pregnancy

¹ Supported by NIH grants HL-58144, HL-72650, and HD-40828.

² Correspondence: C. Yallampalli, Dept. of Obstetrics and Gynecology, University of Texas Medical Branch, 301 University Blvd., MRB, 11.138, Galveston, TX 77555-1062. FAX: 409 747 0475; chyallam{at}utmb.edu

This article has been cited by other articles:

				H. Yamauchi, K.-i. Katayama, M. Ueno, H. Kanemitsu, C. Nam, T. Mikami, A. Saito, Y. Ishida, K. Uetsuka, K. Doi, et al. Etoposide Induces TRP53-Dependent Apoptosis and TRP53-Independent Cell Cycle Arrest in Trophoblasts of the Developing Mouse Placenta Biol Reprod, April 1, 2009; 80(4): 813 - 822. [Abstract] [Full Text] [PDF]